Cardiomyocyte calcium homeostasis is a tightly regulated process. The mitochondrial calcium uniporter (MCU) complex can buffer elevated cytosolic Ca levels and consists of pore-forming proteins including MCU, and various regulatory proteins such as mitochondrial calcium uptake proteins 1 and 2 (MICU1/2). The stoichiometry of these proteins influences the sensitivity to Ca and the activity of the complex. However, the factors that regulate their gene expression remain incompletely understood. Long noncoding RNAs (lncRNAs) regulate gene expression through various mechanisms, and we recently found that the lncRNA increased the expression of and associated genes. To further explore this, we performed antisense LNA knockdown of ( KD) in H9c2 rat cardiomyocytes. KD increased MCU protein expression, yet pyruvate dehydrogenase dephosphorylation, which is indicative of mitochondrial Ca uptake, was not enhanced. However, RNA-seq revealed that KD increased along with differential expression of >1,000 genes including many related to Ca regulation pathways in the heart. To understand the effect of this on Ca signaling, we measured phosphorylation of Ca/calmodulin-dependent protein kinase II (CaMKII) and its downstream target cAMP Response Element-Binding protein (CREB), a transcription factor known to drive gene expression. In response to a Ca stimulus, the increase in CaMKII and CREB phosphorylation was attenuated by KD. Inhibition of CaMKII, but not CREB, partially prevented the KD-mediated increase in . Together, these data suggest that modulates MCU expression via a mechanism involving CaMKII and regulates cardiomyocyte Ca signaling, which could have important implications for cardiac function. Calcium is essential for signaling, excitation contraction, and energy homeostasis in the heart. Despite this, molecular regulators of these processes are not completely understood. We report that knockdown of lncRNA alters the calcium handling transcriptome and increases mitochondrial calcium uniporter expression via a mechanism involving CaMKII. As overexpression of MCU is known to be protective against pathological cardiac remodeling, targeting may be a potential strategy for treating cardiovascular disease.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1152/ajpcell.00339.2023 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!